The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microbiomes Market Research Report 2025
Synopsis
The global Microbiomes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microbiomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbiomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microbiomes in Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microbiomes include 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, Second Genome, Seres Therapeutics, Synlogic and Synthetic Biologics and Vedanta Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbiomes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiomes.
Report Scope
The Microbiomes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiomes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiomes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
SciBac Inc
Segment by Type
Gastrointestinal Microbiome
Genitourinary Microbiome
Skin Microbiome
Respiratory Microbiome
Other
Segment by Application
Testing
Treatment
Diagnosis
Technology Platform
Probiotics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiomes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Microbiomes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microbiomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbiomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microbiomes in Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microbiomes include 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, Second Genome, Seres Therapeutics, Synlogic and Synthetic Biologics and Vedanta Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbiomes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiomes.
Report Scope
The Microbiomes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiomes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiomes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
SciBac Inc
Segment by Type
Gastrointestinal Microbiome
Genitourinary Microbiome
Skin Microbiome
Respiratory Microbiome
Other
Segment by Application
Testing
Treatment
Diagnosis
Technology Platform
Probiotics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiomes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiomes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gastrointestinal Microbiome
1.2.3 Genitourinary Microbiome
1.2.4 Skin Microbiome
1.2.5 Respiratory Microbiome
1.2.6 Other
1.3 Market by Application
1.3.1 Global Microbiomes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Testing
1.3.3 Treatment
1.3.4 Diagnosis
1.3.5 Technology Platform
1.3.6 Probiotics
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbiomes Market Perspective (2019-2030)
2.2 Microbiomes Growth Trends by Region
2.2.1 Global Microbiomes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microbiomes Historic Market Size by Region (2019-2024)
2.2.3 Microbiomes Forecasted Market Size by Region (2025-2030)
2.3 Microbiomes Market Dynamics
2.3.1 Microbiomes Industry Trends
2.3.2 Microbiomes Market Drivers
2.3.3 Microbiomes Market Challenges
2.3.4 Microbiomes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiomes Players by Revenue
3.1.1 Global Top Microbiomes Players by Revenue (2019-2024)
3.1.2 Global Microbiomes Revenue Market Share by Players (2019-2024)
3.2 Global Microbiomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbiomes Revenue
3.4 Global Microbiomes Market Concentration Ratio
3.4.1 Global Microbiomes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiomes Revenue in 2023
3.5 Microbiomes Key Players Head office and Area Served
3.6 Key Players Microbiomes Product Solution and Service
3.7 Date of Enter into Microbiomes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiomes Breakdown Data by Type
4.1 Global Microbiomes Historic Market Size by Type (2019-2024)
4.2 Global Microbiomes Forecasted Market Size by Type (2025-2030)
5 Microbiomes Breakdown Data by Application
5.1 Global Microbiomes Historic Market Size by Application (2019-2024)
5.2 Global Microbiomes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Microbiomes Market Size (2019-2030)
6.2 North America Microbiomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microbiomes Market Size by Country (2019-2024)
6.4 North America Microbiomes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbiomes Market Size (2019-2030)
7.2 Europe Microbiomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microbiomes Market Size by Country (2019-2024)
7.4 Europe Microbiomes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiomes Market Size (2019-2030)
8.2 Asia-Pacific Microbiomes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microbiomes Market Size by Region (2019-2024)
8.4 Asia-Pacific Microbiomes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbiomes Market Size (2019-2030)
9.2 Latin America Microbiomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microbiomes Market Size by Country (2019-2024)
9.4 Latin America Microbiomes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiomes Market Size (2019-2030)
10.2 Middle East & Africa Microbiomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microbiomes Market Size by Country (2019-2024)
10.4 Middle East & Africa Microbiomes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 4D Pharma
11.1.1 4D Pharma Company Detail
11.1.2 4D Pharma Business Overview
11.1.3 4D Pharma Microbiomes Introduction
11.1.4 4D Pharma Revenue in Microbiomes Business (2019-2024)
11.1.5 4D Pharma Recent Development
11.2 Enterome BioScience
11.2.1 Enterome BioScience Company Detail
11.2.2 Enterome BioScience Business Overview
11.2.3 Enterome BioScience Microbiomes Introduction
11.2.4 Enterome BioScience Revenue in Microbiomes Business (2019-2024)
11.2.5 Enterome BioScience Recent Development
11.3 Evelo Biosciences
11.3.1 Evelo Biosciences Company Detail
11.3.2 Evelo Biosciences Business Overview
11.3.3 Evelo Biosciences Microbiomes Introduction
11.3.4 Evelo Biosciences Revenue in Microbiomes Business (2019-2024)
11.3.5 Evelo Biosciences Recent Development
11.4 Ferring
11.4.1 Ferring Company Detail
11.4.2 Ferring Business Overview
11.4.3 Ferring Microbiomes Introduction
11.4.4 Ferring Revenue in Microbiomes Business (2019-2024)
11.4.5 Ferring Recent Development
11.5 Osel
11.5.1 Osel Company Detail
11.5.2 Osel Business Overview
11.5.3 Osel Microbiomes Introduction
11.5.4 Osel Revenue in Microbiomes Business (2019-2024)
11.5.5 Osel Recent Development
11.6 Second Genome
11.6.1 Second Genome Company Detail
11.6.2 Second Genome Business Overview
11.6.3 Second Genome Microbiomes Introduction
11.6.4 Second Genome Revenue in Microbiomes Business (2019-2024)
11.6.5 Second Genome Recent Development
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Detail
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Microbiomes Introduction
11.7.4 Seres Therapeutics Revenue in Microbiomes Business (2019-2024)
11.7.5 Seres Therapeutics Recent Development
11.8 Synlogic
11.8.1 Synlogic Company Detail
11.8.2 Synlogic Business Overview
11.8.3 Synlogic Microbiomes Introduction
11.8.4 Synlogic Revenue in Microbiomes Business (2019-2024)
11.8.5 Synlogic Recent Development
11.9 Synthetic Biologics and Vedanta Biosciences
11.9.1 Synthetic Biologics and Vedanta Biosciences Company Detail
11.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
11.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Introduction
11.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2019-2024)
11.9.5 Synthetic Biologics and Vedanta Biosciences Recent Development
11.10 Vedanta
11.10.1 Vedanta Company Detail
11.10.2 Vedanta Business Overview
11.10.3 Vedanta Microbiomes Introduction
11.10.4 Vedanta Revenue in Microbiomes Business (2019-2024)
11.10.5 Vedanta Recent Development
11.11 Rebiotix
11.11.1 Rebiotix Company Detail
11.11.2 Rebiotix Business Overview
11.11.3 Rebiotix Microbiomes Introduction
11.11.4 Rebiotix Revenue in Microbiomes Business (2019-2024)
11.11.5 Rebiotix Recent Development
11.12 ActoGeniX
11.12.1 ActoGeniX Company Detail
11.12.2 ActoGeniX Business Overview
11.12.3 ActoGeniX Microbiomes Introduction
11.12.4 ActoGeniX Revenue in Microbiomes Business (2019-2024)
11.12.5 ActoGeniX Recent Development
11.13 Enterologics
11.13.1 Enterologics Company Detail
11.13.2 Enterologics Business Overview
11.13.3 Enterologics Microbiomes Introduction
11.13.4 Enterologics Revenue in Microbiomes Business (2019-2024)
11.13.5 Enterologics Recent Development
11.14 Metabogen
11.14.1 Metabogen Company Detail
11.14.2 Metabogen Business Overview
11.14.3 Metabogen Microbiomes Introduction
11.14.4 Metabogen Revenue in Microbiomes Business (2019-2024)
11.14.5 Metabogen Recent Development
11.15 Metabiomics
11.15.1 Metabiomics Company Detail
11.15.2 Metabiomics Business Overview
11.15.3 Metabiomics Microbiomes Introduction
11.15.4 Metabiomics Revenue in Microbiomes Business (2019-2024)
11.15.5 Metabiomics Recent Development
11.16 Ritter Pharmaceuticals
11.16.1 Ritter Pharmaceuticals Company Detail
11.16.2 Ritter Pharmaceuticals Business Overview
11.16.3 Ritter Pharmaceuticals Microbiomes Introduction
11.16.4 Ritter Pharmaceuticals Revenue in Microbiomes Business (2019-2024)
11.16.5 Ritter Pharmaceuticals Recent Development
11.17 AvidBiotics
11.17.1 AvidBiotics Company Detail
11.17.2 AvidBiotics Business Overview
11.17.3 AvidBiotics Microbiomes Introduction
11.17.4 AvidBiotics Revenue in Microbiomes Business (2019-2024)
11.17.5 AvidBiotics Recent Development
11.18 Symberix
11.18.1 Symberix Company Detail
11.18.2 Symberix Business Overview
11.18.3 Symberix Microbiomes Introduction
11.18.4 Symberix Revenue in Microbiomes Business (2019-2024)
11.18.5 Symberix Recent Development
11.19 Miomics
11.19.1 Miomics Company Detail
11.19.2 Miomics Business Overview
11.19.3 Miomics Microbiomes Introduction
11.19.4 Miomics Revenue in Microbiomes Business (2019-2024)
11.19.5 Miomics Recent Development
11.20 Symbiotix Biotherapies
11.20.1 Symbiotix Biotherapies Company Detail
11.20.2 Symbiotix Biotherapies Business Overview
11.20.3 Symbiotix Biotherapies Microbiomes Introduction
11.20.4 Symbiotix Biotherapies Revenue in Microbiomes Business (2019-2024)
11.20.5 Symbiotix Biotherapies Recent Development
11.21 MicroBiome Therapeutics LLC
11.21.1 MicroBiome Therapeutics LLC Company Detail
11.21.2 MicroBiome Therapeutics LLC Business Overview
11.21.3 MicroBiome Therapeutics LLC Microbiomes Introduction
11.21.4 MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2019-2024)
11.21.5 MicroBiome Therapeutics LLC Recent Development
11.22 SciBac Inc
11.22.1 SciBac Inc Company Detail
11.22.2 SciBac Inc Business Overview
11.22.3 SciBac Inc Microbiomes Introduction
11.22.4 SciBac Inc Revenue in Microbiomes Business (2019-2024)
11.22.5 SciBac Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Microbiomes Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gastrointestinal Microbiome
Table 3. Key Players of Genitourinary Microbiome
Table 4. Key Players of Skin Microbiome
Table 5. Key Players of Respiratory Microbiome
Table 6. Key Players of Other
Table 7. Global Microbiomes Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Microbiomes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Microbiomes Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Microbiomes Market Share by Region (2019-2024)
Table 11. Global Microbiomes Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Microbiomes Market Share by Region (2025-2030)
Table 13. Microbiomes Market Trends
Table 14. Microbiomes Market Drivers
Table 15. Microbiomes Market Challenges
Table 16. Microbiomes Market Restraints
Table 17. Global Microbiomes Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Microbiomes Market Share by Players (2019-2024)
Table 19. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiomes as of 2023)
Table 20. Ranking of Global Top Microbiomes Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Microbiomes Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Microbiomes Product Solution and Service
Table 24. Date of Enter into Microbiomes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microbiomes Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Microbiomes Revenue Market Share by Type (2019-2024)
Table 28. Global Microbiomes Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Microbiomes Revenue Market Share by Type (2025-2030)
Table 30. Global Microbiomes Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Microbiomes Revenue Market Share by Application (2019-2024)
Table 32. Global Microbiomes Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Microbiomes Revenue Market Share by Application (2025-2030)
Table 34. North America Microbiomes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Microbiomes Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Microbiomes Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Microbiomes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Microbiomes Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Microbiomes Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Microbiomes Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Microbiomes Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Microbiomes Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Microbiomes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Microbiomes Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Microbiomes Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Microbiomes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Microbiomes Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Microbiomes Market Size by Country (2025-2030) & (US$ Million)
Table 49. 4D Pharma Company Detail
Table 50. 4D Pharma Business Overview
Table 51. 4D Pharma Microbiomes Product
Table 52. 4D Pharma Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 53. 4D Pharma Recent Development
Table 54. Enterome BioScience Company Detail
Table 55. Enterome BioScience Business Overview
Table 56. Enterome BioScience Microbiomes Product
Table 57. Enterome BioScience Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 58. Enterome BioScience Recent Development
Table 59. Evelo Biosciences Company Detail
Table 60. Evelo Biosciences Business Overview
Table 61. Evelo Biosciences Microbiomes Product
Table 62. Evelo Biosciences Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 63. Evelo Biosciences Recent Development
Table 64. Ferring Company Detail
Table 65. Ferring Business Overview
Table 66. Ferring Microbiomes Product
Table 67. Ferring Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 68. Ferring Recent Development
Table 69. Osel Company Detail
Table 70. Osel Business Overview
Table 71. Osel Microbiomes Product
Table 72. Osel Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 73. Osel Recent Development
Table 74. Second Genome Company Detail
Table 75. Second Genome Business Overview
Table 76. Second Genome Microbiomes Product
Table 77. Second Genome Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 78. Second Genome Recent Development
Table 79. Seres Therapeutics Company Detail
Table 80. Seres Therapeutics Business Overview
Table 81. Seres Therapeutics Microbiomes Product
Table 82. Seres Therapeutics Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 83. Seres Therapeutics Recent Development
Table 84. Synlogic Company Detail
Table 85. Synlogic Business Overview
Table 86. Synlogic Microbiomes Product
Table 87. Synlogic Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 88. Synlogic Recent Development
Table 89. Synthetic Biologics and Vedanta Biosciences Company Detail
Table 90. Synthetic Biologics and Vedanta Biosciences Business Overview
Table 91. Synthetic Biologics and Vedanta Biosciences Microbiomes Product
Table 92. Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 93. Synthetic Biologics and Vedanta Biosciences Recent Development
Table 94. Vedanta Company Detail
Table 95. Vedanta Business Overview
Table 96. Vedanta Microbiomes Product
Table 97. Vedanta Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 98. Vedanta Recent Development
Table 99. Rebiotix Company Detail
Table 100. Rebiotix Business Overview
Table 101. Rebiotix Microbiomes Product
Table 102. Rebiotix Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 103. Rebiotix Recent Development
Table 104. ActoGeniX Company Detail
Table 105. ActoGeniX Business Overview
Table 106. ActoGeniX Microbiomes Product
Table 107. ActoGeniX Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 108. ActoGeniX Recent Development
Table 109. Enterologics Company Detail
Table 110. Enterologics Business Overview
Table 111. Enterologics Microbiomes Product
Table 112. Enterologics Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 113. Enterologics Recent Development
Table 114. Metabogen Company Detail
Table 115. Metabogen Business Overview
Table 116. Metabogen Microbiomes Product
Table 117. Metabogen Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 118. Metabogen Recent Development
Table 119. Metabiomics Company Detail
Table 120. Metabiomics Business Overview
Table 121. Metabiomics Microbiomes Product
Table 122. Metabiomics Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 123. Metabiomics Recent Development
Table 124. Ritter Pharmaceuticals Company Detail
Table 125. Ritter Pharmaceuticals Business Overview
Table 126. Ritter Pharmaceuticals Microbiomes Product
Table 127. Ritter Pharmaceuticals Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 128. Ritter Pharmaceuticals Recent Development
Table 129. AvidBiotics Company Detail
Table 130. AvidBiotics Business Overview
Table 131. AvidBiotics Microbiomes Product
Table 132. AvidBiotics Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 133. AvidBiotics Recent Development
Table 134. Symberix Company Detail
Table 135. Symberix Business Overview
Table 136. Symberix Microbiomes Product
Table 137. Symberix Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 138. Symberix Recent Development
Table 139. Miomics Company Detail
Table 140. Miomics Business Overview
Table 141. Miomics Microbiomes Product
Table 142. Miomics Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 143. Miomics Recent Development
Table 144. Symbiotix Biotherapies Company Detail
Table 145. Symbiotix Biotherapies Business Overview
Table 146. Symbiotix Biotherapies Microbiomes Product
Table 147. Symbiotix Biotherapies Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 148. Symbiotix Biotherapies Recent Development
Table 149. MicroBiome Therapeutics LLC Company Detail
Table 150. MicroBiome Therapeutics LLC Business Overview
Table 151. MicroBiome Therapeutics LLC Microbiomes Product
Table 152. MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 153. MicroBiome Therapeutics LLC Recent Development
Table 154. SciBac Inc Company Detail
Table 155. SciBac Inc Business Overview
Table 156. SciBac Inc Microbiomes Product
Table 157. SciBac Inc Revenue in Microbiomes Business (2019-2024) & (US$ Million)
Table 158. SciBac Inc Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiomes Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Microbiomes Market Share by Type: 2023 VS 2030
Figure 3. Gastrointestinal Microbiome Features
Figure 4. Genitourinary Microbiome Features
Figure 5. Skin Microbiome Features
Figure 6. Respiratory Microbiome Features
Figure 7. Other Features
Figure 8. Global Microbiomes Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Microbiomes Market Share by Application: 2023 VS 2030
Figure 10. Testing Case Studies
Figure 11. Treatment Case Studies
Figure 12. Diagnosis Case Studies
Figure 13. Technology Platform Case Studies
Figure 14. Probiotics Case Studies
Figure 15. Other Case Studies
Figure 16. Microbiomes Report Years Considered
Figure 17. Global Microbiomes Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Microbiomes Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Microbiomes Market Share by Region: 2023 VS 2030
Figure 20. Global Microbiomes Market Share by Players in 2023
Figure 21. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiomes as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Microbiomes Revenue in 2023
Figure 23. North America Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Microbiomes Market Share by Country (2019-2030)
Figure 25. United States Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Microbiomes Market Share by Country (2019-2030)
Figure 29. Germany Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Microbiomes Market Share by Region (2019-2030)
Figure 37. China Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Microbiomes Market Share by Country (2019-2030)
Figure 45. Mexico Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Microbiomes Market Share by Country (2019-2030)
Figure 49. Turkey Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Microbiomes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. 4D Pharma Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 52. Enterome BioScience Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 53. Evelo Biosciences Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 54. Ferring Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 55. Osel Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 56. Second Genome Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 57. Seres Therapeutics Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 58. Synlogic Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 59. Synthetic Biologics and Vedanta Biosciences Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 60. Vedanta Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 61. Rebiotix Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 62. ActoGeniX Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 63. Enterologics Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 64. Metabogen Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 65. Metabiomics Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 66. Ritter Pharmaceuticals Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 67. AvidBiotics Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 68. Symberix Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 69. Miomics Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 70. Symbiotix Biotherapies Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 71. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 72. SciBac Inc Revenue Growth Rate in Microbiomes Business (2019-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
